• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Immunol . A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndr

tetano

Editor, Senior Moderator
J Immunol


. 2025 Mar 18:vkaf006.
doi: 10.1093/jimmun/vkaf006. Online ahead of print. A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome

Rehan Khan[SUP] 1 [/SUP], Weizhen Ji[SUP] 2 [/SUP], Jeisac Guzman Rivera[SUP] 1 [/SUP], Abhilasha Madhvi[SUP] 1 [/SUP], Tracy Andrews[SUP] 3 [/SUP], Benjamin Richlin[SUP] 4 [/SUP], Christian Suarez[SUP] 4 [/SUP], Sunanda Gaur[SUP] 5 [/SUP], Uzma N Hasan[SUP] 6 [/SUP], William Cuddy[SUP] 7 [/SUP], Aalok R Singh[SUP] 7 8 [/SUP], Hulya Bukulmez[SUP] 9 [/SUP], David Kaelber[SUP] 9 10 11 [/SUP], Yukiko Kimura[SUP] 12 [/SUP], Usha Ganapathi[SUP] 1 [/SUP], Ioannis E Michailidis[SUP] 1 [/SUP], Rahul Ukey[SUP] 1 [/SUP], Sandra Moroso-Fela[SUP] 13 [/SUP], John K Kuster[SUP] 2 [/SUP], Myriam Casseus[SUP] 13 [/SUP], Jason Roy[SUP] 3 [/SUP], Jane C Burns[SUP] 14 15 [/SUP], Lawrence C Kleinman[SUP] 13 16 [/SUP], Daniel B Horton[SUP] 3 13 17 [/SUP], Saquib A Lakhani[SUP] 2 [/SUP], Maria Laura Gennaro[SUP] 1 18 [/SUP]



Affiliations
Abstract

Dysregulated innate immune responses contribute to multisystem inflammatory syndrome in children (MIS-C), characterized by gastrointestinal, mucocutaneous, and/or cardiovascular injury occurring weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure. To investigate innate immune functions, we stimulated ex vivo peripheral blood cells from MIS-C patients with agonists of Toll-like receptors (TLR), key innate immune response initiators. We found severely dampened cytokine responses and elevated gene expression of negative regulators of TLR signaling. Increased plasma levels of zonulin, a gut leakage marker, were also detected. These effects were also observed in fully convalescent children months after MIS-C recovery. When we investigated the genetic background of patients in relation to TLR responsiveness, we found that cells from MIS-C children carrying rare heterozygous variants of lysosomal trafficking regulator (LYST) were less refractory to TLR stimulation and exhibited lysosomal and mitochondrial abnormalities with altered energy metabolism. Moreover, these rare LYST variant heterozygous carriers tended to exhibit unfavorable clinical laboratory indicators of inflammation, including more profound lymphopenia. The results of our observational study have several implications. First, TLR hyporesponsiveness may be associated with hyperinflammation and/or excessive or prolonged stimulation with gut-originated TLR ligands. Second, TLR hyporesponsiveness during MIS-C may be protective, since LYST variant heterozygous carriers exhibited reduced TLR hyporesponsiveness and unfavorable clinical laboratory indicators of inflammation. Thus, links may exist between genetic background, ability to establish a refractory immune state, and MIS-C clinical spectrum. Third, the possibility exists that prolonged TLR hyporesponsiveness is one of the mechanisms driving long coronavirus disease (COVID), which highlights the need to monitor long-term consequences of MIS-C.

Keywords: LYST; MIS-C; SARS-CoV-2; genetic variants; hyperinflammatory syndrome; innate immunity.

 
Back
Top Bottom